Author

M. Graupera

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Carracedo· 1 shared A. Esteve-Codina· 1 shared A. Loizaga· 1 shared A. M. Aransay· 1 shared A. Macchia· 1 shared A. R. Cortazar· 1 shared A. Santos· 1 shared A. Schaub· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Carracedo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunoregulatory subtype of dermal lymphatic endothelial cells at capillary terminals drives lymphatic malformations

M. Petkova, M. Kraft, S. Stritt, I. Martinez-Corral, H. Ortsater, Y. Sun, M. Vanlandewijck, B. Jakic, E. Baselga, S. D. Castillo, M. Graupera, C. Betsholtz, T. Makinen

The paper identifies an immunoregulatory subtype of lymphatic endothelial cells that drives lymphatic malformations through pro-inflammatory signaling and immune cell interactions.

bioRxiv · May 22, 2022Cell Biology

Loss of the RNA helicase Dhx15 impairs endothelial energy metabolism, lymphatic drainage and tumor metastasis in mice

J. Ribera, I. Portoles, B. Cordoba-Jover, J. Rodriguez-Vita, G. Casals, B. Gonzalez-de la Presa, M. Graupera, G. Soria, R. Tudela, A. Esteve-Codina, G. Espadas, E. Sabido, W. Jimenez, W. C. Sessa, M. Morales-Ruiz

bioRxiv · Nov 3, 2020 · PreprintCell Biology

Integrative analysis of transcriptomic and clinical data uncovers the tumor suppressive activity of MITF in prostate cancer.

L. Valcarcel, A. Macchia, N. Martin, A. R. Cortazar, A. Schaub, M. Pujana, S. Fernandez, I. Lacasa, A. Santos, A. Loizaga, M. Unda, I. Hermanova, I. Astobiza, M. Graupera, J. Starkova, , V. Torrano

The paper identifies MITF as a tumor suppressor in prostate cancer and reveals CRYAB as a direct target mediating its suppressive activity through integrative transcriptomic and clinical analysis.

bioRxiv · Aug 14, 2018Cancer Biology